Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › sarcoma

Sarcoma

Part of Epithelioid Sarcoma

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for sarcoma

80 trials tracked for sarcoma: 5 in phase 3 or 4.

80Trials tracked
5Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 5 Phase 2 55 Phase 1 7 Other / NA 13
  1. Phase 3 Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy Completed
  2. Phase 3 High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma Completed
  3. Phase 3 An Efficacy and Safety Study of Trabectedin Versus Doxorubicin-Based Chemotherapy in Participants With Translocation-Related Sarcomas (TRS) Completed
  4. Phase 3 Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Completed
  5. Phase 3 Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Completed
  6. Phase 2 A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers Completed
Show 44 more trials
  1. Phase 2 Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors Completed
  2. Phase 2 Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma Completed
  3. Phase 2 Pembrolizumab and Doxorubicin Hydrochloride in Treating Patients With Sarcoma That is Metastatic or Cannot Be Removed by Surgery Completed
  4. Phase 2 Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma Completed
  5. Phase 2 A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas Completed
  6. Phase 2 Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas Completed
  7. Phase 2 PD0332991 (Palbociclib) in Patients With Advanced or Metastatic Liposarcoma Completed
  8. Phase 2 Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer Completed
  9. Phase 2 Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma Completed
  10. Phase 2 Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma Completed
  11. Phase 2 Vatalanib in Treating Patients With Recurrent or Progressive Meningioma Completed
  12. Phase 2 A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis Completed
  13. Phase 2 Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor Completed
  14. Phase 2 Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma Completed
  15. Phase 2 Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma Completed
  16. Phase 2 Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors Completed
  17. Phase 2 Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors Completed
  18. Phase 2 Trivalent Ganglioside Vaccine With Immunological Adjuvant or Immunological Adjuvant Alone in Metastatic Sarcoma Patients Who Are Rendered Disease Free Completed
  19. Phase 2 Combination of MK3475 and Metronomic Cyclophosphamide in Patients With Advanced Sarcomas : Multicentre Phase II Trial Completed
  20. Phase 2 Trabectedin in Combination With Olaparib in Advanced Unresectable or Metastatic Sarcoma Completed
  21. Phase 2 S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas Completed
  22. Phase 2 Sorafenib and Dacarbazine in Soft Tissue Sarcoma Completed
  23. Phase 2 Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma Completed
  24. Phase 2 A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 Completed
  25. Phase 2 Study of Vorinostat in Combination With Gemcitabine and Docetaxel in Advanced Sarcoma Completed
  26. Phase 2 Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer Completed
  27. Phase 2 SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors Completed
  28. Phase 2 Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma Completed
  29. Phase 2 Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes Completed
  30. Phase 2 Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection Completed
  31. Phase 2 Busulfan, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk Ewing's Tumors Completed
  32. Phase 2 Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) Completed
  33. Phase 2 Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma Completed
  34. Phase 2 Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma Completed
  35. Phase 2 Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma Completed
  36. Phase 2 Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas Completed
  37. Phase 2 A Phase II Trial Comparing Gemcitabine and Pazopanib Versus Gemcitabine and Docetaxel for Patients With Advanced Soft Tissue Sarcoma Completed
  38. Phase 2 Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Sarcoma Completed
  39. Phase 2 PCI-24781 in Combination With Doxorubicin to Treat Sarcoma Completed
  40. Phase 2 Bevacizumab in Treating Patients With Angiosarcoma Completed
  41. Phase 2 S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor Completed
  42. Phase 2 Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer Completed
  43. Phase 2 Adjuvant Imatinib in High-risk Gastrointestinal Stromal Tumor (GIST) With C-kit Mutation Completed
  44. Phase 2 Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg Completed

Showing the 50 most-cited and recently-updated of 80 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.